Literature DB >> 1808134

Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.

H P Niendorf1, J Haustein, T Louton, W Beck, M Laniado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1808134     DOI： 10.1097/00004424-199111001-00075

Source DB:  PubMed          Journal:  Invest Radiol        ISSN： 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  5 in total

1.  Gadolinium use in spine procedures for patients with allergy to iodinated contrast--experience of 127 procedures.

Authors:  Y Safriel; M Ali; M Hayt; R Ang
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 2.  Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments.

Authors:  A Mühler
Journal:  MAGMA       Date:  1995-03       Impact factor: 2.310

3.  Gadolinium-enhanced MR cisternography to evaluate dural leaks in intracranial hypotension syndrome.

Authors:  S Albayram; F Kilic; H Ozer; S Baghaki; N Kocer; C Islak
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-18       Impact factor: 3.825

4.  A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.

Authors:  Jason M Elinoff; J Eduardo Rame; Paul R Forfia; Mary K Hall; Junfeng Sun; Ahmed M Gharib; Khaled Abd-Elmoniem; Grace Graninger; Bonnie Harper; Robert L Danner; Michael A Solomon
Journal:  Trials       Date:  2013-04-02       Impact factor: 2.279

5.  Intrathecal gadolinium-enhanced MR cisternography in the evaluation of CSF leakage.

Authors:  H Selcuk; S Albayram; H Ozer; S Ulus; G Z Sanus; M Y Kaynar; N Kocer; C Islak
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-17       Impact factor: 4.966
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.